about
CXCL12 modulation of CXCR4 and CXCR7 activity in human glioblastoma stem-like cells and regulation of the tumor microenvironment.The role of chemoattractant receptors in shaping the tumor microenvironment.The emerging role of CXC chemokines and their receptors in cancer.CXCR3 antagonism of SDF-1(5-67) restores trabecular function and prevents retinal neurodegeneration in a rat model of ocular hypertension.Chemoattractant receptors as pharmacological targets for elimination of glioma stem-like cells.Hormones and immunity in cancer: are thyroid hormones endocrine players in the microglia/glioma cross-talk?CCL5, CCR1 and CCR5 in murine glioblastoma: immune cell infiltration and survival rates are not dependent on individual expression of either CCR1 or CCR5Evaluation of TgH(CX3CR1-EGFP) mice implanted with mCherry-GL261 cells as an in vivo model for morphometrical analysis of glioma-microglia interactionEffect of CXCL10 receptor antagonist on islet cell apoptosis in a type I diabetes rat model.Visualization of implanted GL261 glioma cells in living mouse brain slices using fluorescent 4-(4-(dimethylamino)-styryl)-N-methylpyridinium iodide (ASP+)The integrated landscape of driver genomic alterations in glioblastoma.CXCL9: evidence and contradictions for its role in tumor progression.IP-10/CXCL10 induction in human pancreatic cancer stroma influences lymphocytes recruitment and correlates with poor survival.CXCR3 deficiency enhances tumor progression by promoting macrophage M2 polarization in a murine breast cancer model.Cancer cell-derived lymphotoxin mediates reciprocal tumour-stromal interactions in human ovarian cancer by inducing CXCL11 in fibroblasts.CXC and CC chemokines as angiogenic modulators in nonhaematological tumors.Ligand activation induces different conformational changes in CXCR3 receptor isoforms as evidenced by plasmon waveguide resonance (PWR).The role of CXCR3/LRP1 cross-talk in the invasion of primary brain tumors.High expression of CXCR3 is an independent prognostic factor in glioblastoma patients that promotes an invasive phenotype.
P2860
Q33677057-4D2EB246-D73F-40A5-99DD-C1690D6B4B42Q33993124-067AA2E8-CE54-4A0D-8834-475319B0C5FCQ34263645-77AA8FC6-2AFF-4E17-97DA-801D3D8D6130Q34295638-3A67DBE9-30F6-4B98-8136-8527A9A17EA2Q35573448-CA7AE15F-5320-4AEC-80F2-4D6B24C6BCB2Q35768957-4644D669-44E4-4436-B21F-EA06A3DD2243Q35911313-6B492185-241A-4B08-9300-67C3B0E142D6Q35917464-4C3A460C-0C6D-4E33-830B-787FBF7E9815Q36464500-F2796831-E35D-4756-B426-7B262D3740B9Q36886253-BBDDD9BC-39C6-473B-88AE-43ED1396ED88Q37237987-23A65E67-72A9-4279-9E5A-F0D58780D205Q37429985-BD688868-5C4F-4BBB-9E85-DEFD8A7292C7Q38938649-6E0A40F8-424E-4336-BC52-5698AE51C3AAQ39010600-1082CA93-470B-41BD-8DA5-757EAA5ED679Q39098568-A8EC0EDF-3256-4514-B827-E6B68D6388ABQ40724369-50E8C4BE-8EA2-4A4F-8BC2-C46F86E86F6AQ41628251-1AA57565-1734-4F59-AF75-7B0E1F5826C5Q44449800-42B92635-4D11-41B5-8120-468C955E4F0DQ48405321-568F0386-34B0-4791-91BA-7E93EF6C25E6
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Chemokine receptor CXCR3 promotes growth of glioma.
@ast
Chemokine receptor CXCR3 promotes growth of glioma.
@en
Chemokine receptor CXCR3 promotes growth of glioma.
@nl
type
label
Chemokine receptor CXCR3 promotes growth of glioma.
@ast
Chemokine receptor CXCR3 promotes growth of glioma.
@en
Chemokine receptor CXCR3 promotes growth of glioma.
@nl
prefLabel
Chemokine receptor CXCR3 promotes growth of glioma.
@ast
Chemokine receptor CXCR3 promotes growth of glioma.
@en
Chemokine receptor CXCR3 promotes growth of glioma.
@nl
P2093
P2860
P356
P1433
P1476
Chemokine receptor CXCR3 promotes growth of glioma.
@en
P2093
Brent A Reynolds
Craig J Gerard
Cyrus P Bhadha
Defang Luo
Geeta Meher
Jeffrey K Harrison
P2860
P304
P356
10.1093/CARCIN/BGQ224
P407
P577
2010-11-03T00:00:00Z